Dec 15 |
AC Immune prices its 14.3M shares offering
|
Dec 15 |
AC Immune Announces Pricing of Underwritten Offering of Common Shares
|
Dec 15 |
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
|
Dec 13 |
AC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held by individual investors
|
Dec 11 |
Alzheimer's Disease Space Evolves in 2023: Stocks in Focus
|
Dec 5 |
Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now?
|
Dec 1 |
AC Immune makes interim CFO Christopher Roberts permanent
|
Dec 1 |
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
|
Nov 27 |
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
|
Nov 3 |
AC Immune GAAP EPS of -$0.18 misses by $0.20
|